Metropolitan Life Insurance Company (MetLife)’s Ameren AEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,605
Closed -$784K 55
2024
Q1
$784K Sell
10,605
-97
-0.9% -$6.9K 0.03% 378
2023
Q4
$774K Sell
10,702
-169
-2% -$12.9K 0.04% 365
2023
Q3
$813K Sell
10,871
-572
-5% -$46.6K 0.04% 338
2023
Q2
$935K Sell
11,443
-120
-1% -$10.3K 0.05% 333
2023
Q1
$999K Sell
11,563
-3,388
-23% -$290K 0.05% 320
2022
Q4
$1.33M Sell
14,951
-429
-3% -$36.1K 0.06% 305
2022
Q3
$1.24M Sell
15,380
-172
-1% -$15.7K 0.06% 303
2022
Q2
$1.41M Sell
15,552
-345
-2% -$31.9K 0.06% 291
2022
Q1
$1.49M Sell
15,897
-13,484
-46% -$1.18M 0.05% 318
2021
Q4
$2.62M Sell
29,381
-809
-3% -$68.7K 0.04% 410
2021
Q3
$2.45M Sell
30,190
-864
-3% -$73.7K 0.04% 414
2021
Q2
$2.49M Sell
31,054
-93
-0.3% -$7.79K 0.04% 427
2021
Q1
$2.53M Sell
31,147
-871
-3% -$65.3K 0.04% 413
2020
Q4
$2.5M Sell
32,018
-1,692
-5% -$136K 0.04% 390
2020
Q3
$2.67M Sell
33,710
-1,466
-4% -$115K 0.05% 331
2020
Q2
$2.47M Sell
35,176
-2,018
-5% -$146K 0.04% 342
2020
Q1
$2.71M Sell
37,194
-142
-0.4% -$11.3K 0.06% 289
2019
Q4
$2.87M Buy
37,336
+819
+2% +$62.2K 0.05% 355
2019
Q3
$2.92M Buy
36,517
+177
+0.5% +$13.6K 0.05% 327
2019
Q2
$2.73M Buy
36,340
+2,996
+9% +$221K 0.05% 364
2019
Q1
$2.45M Sell
33,344
-1,444
-4% -$101K 0.04% 384
2018
Q4
$2.27M Sell
34,788
-784
-2% -$52.3K 0.05% 360
2018
Q3
$2.25M Sell
35,572
-1,285
-3% -$80.9K 0.04% 448
2018
Q2
$2.24M Sell
36,857
-948
-3% -$54.5K 0.04% 455
2018
Q1
$2.14M Buy
37,805
+226
+0.6% +$12.5K 0.03% 491
2017
Q4
$2.22M Sell
37,579
-77,626
-67% -$4.77M 0.03% 483
2017
Q3
$6.66M Sell
115,205
-2,440
-2% -$141K 0.04% 409
2017
Q2
$6.43M Sell
117,645
-3,136
-3% -$174K 0.04% 423
2017
Q1
$6.59M Sell
120,781
-1,880
-2% -$101K 0.05% 413
2016
Q4
$6.43M Sell
122,661
-2,963
-2% -$147K 0.05% 422
2016
Q3
$6.18M Sell
125,624
-883
-0.7% -$45.1K 0.05% 417
2016
Q2
$6.78M Sell
126,507
-1,287
-1% -$63.3K 0.05% 367
2016
Q1
$6.4M Sell
127,794
-2,700
-2% -$125K 0.05% 390
2015
Q4
$5.64M Sell
130,494
-2,322
-2% -$101K 0.04% 442
2015
Q3
$5.61M Sell
132,816
-2,411
-2% -$97.1K 0.04% 446
2015
Q2
$5.09M Sell
135,227
-1,111
-0.8% -$44.6K 0.04% 533
2015
Q1
$5.75M Sell
136,338
-1,768
-1% -$76.9K 0.04% 460
2014
Q4
$6.37M Sell
138,106
-1,041
-0.7% -$44.3K 0.04% 419
2014
Q3
$5.33M Sell
139,147
-2,007
-1% -$78.5K 0.04% 469
2014
Q2
$5.77M Sell
141,154
-6,919
-5% -$276K 0.04% 468
2014
Q1
$6.1M Sell
148,073
-2,268
-2% -$87.4K 0.04% 441
2013
Q4
$5.44M Sell
150,341
-3,064
-2% -$110K 0.04% 480
2013
Q3
$5.34M Sell
153,405
-789
-0.5% -$27.3K 0.04% 459
2013
Q2
$5.31M Buy
+154,194
New +$5.39M 0.04% 430

Other funds holding AEE

Metropolitan Life Insurance Company (MetLife)'s AEE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ameren (AEE) in Q2 2024, closing a stake of 10,605 shares — an estimated $784K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AEE in Q2 2013 and held it in 44 quarters. The position peaked at $6.78M in Q2 2016. 662 funds tracked by Wall St. Rank hold AEE as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ameren position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 10,605 Ameren shares in Q2 2024, an estimated $784K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ameren in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ameren position peaked at $6.78M in Q2 2016.
  • 662 funds tracked by Wall St. Rank held Ameren as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.